Avivo is on a mission to save lives by increasing the number of organ transplants and expanding the available blood supply. Our enzymes eliminate the blood type barrier in blood transfusion and organ transplantation by converting all blood types to Type O, the universal donor type. As a dual-use technology, Avivo sits at the intersection of military trauma and donor organ utilization.  In a world first, the company has completed its proof-of-concept study by implanting an Enzyme Converted Type O (ECO) organ into a blood type mismatched human decedent kidney transplant model and is advancing its programs toward first in human clinical trials.

Avivo Biomedical Inc.

Org chart

Teams

Offices